Breast Cancer Clinical Trials in Beijing, Beijing Municipality
35 recruitingBeijing, Beijing Municipality, China
Showing 1–20 of 35 trials
Recruiting
Phase 1
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
Breast CancerAdvanced Solid Tumor
BeOne Medicines86 enrolled10 locationsNCT07222267
Recruiting
Phase 1
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
Breast CancerGastric CancerOvarian Cancer+1 more
BeiGene258 enrolled24 locationsNCT06257264
Recruiting
Phase 3
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Breast Cancer
Pfizer1,020 enrolled518 locationsNCT06760637
Recruiting
Phase 1Phase 2
Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
Breast CancerCancer
Essen Biotech85 enrolled1 locationNCT07410494
Recruiting
Phase 2
Response-Based Local Therapy for Regionally Advanced Breast Cancer
Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences157 enrolled1 locationNCT07376538
Recruiting
Phase 1
A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors
Breast CancerSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.20 enrolled1 locationNCT06609187
Recruiting
Phase 3
Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)
Breast Cancer
Fudan University764 enrolled15 locationsNCT05909332
Recruiting
Phase 3
A Randomised, Open-label, Multicentre Phase III Clinical Study to Evaluate the Efficacy and Safety of JS105 Combined With Dalpiciclib and Fulvestrant Compared With Dalpiciclib and Fulvestrant in Patients With PIK3CA-mutated, HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer.
Breast Cancer
Risen (Suzhou) Pharma Tech Co., Ltd.312 enrolled2 locationsNCT07207070
Recruiting
Evaluation of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Real-World Study
Breast CancerTrop2Brain Metastases From Breast Cancer
Peking University Cancer Hospital & Institute100 enrolled1 locationNCT07251868
Recruiting
Phase 2
A Study of YL202 in Selected Patients With Advanced Solid Tumors
Breast CancerNSCLCHNSCC+1 more
MediLink Therapeutics (Suzhou) Co., Ltd.200 enrolled82 locationsNCT06107686
Recruiting
Phase 2
A Phase IIa Study to Evaluate NBQ72S
Breast Cancer
Nantong Bencao Quadriga Medical Technology Co. Ltd.10 enrolled1 locationNCT06810804
Recruiting
Phase 3
Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer
Breast Cancer
Laekna Limited256 enrolled55 locationsNCT04851613
Recruiting
Not Applicable
Exploration of the Safety and Efficacy of T-DXd Concurrent With Brain Radiotherapy in Patients With Brain Metastases HER2-positive/HER2-low Advanced Breast Cancer
Breast Cancer
QIAO LI40 enrolled1 locationNCT07117864
Recruiting
Phase 3
A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.642 enrolled25 locationsNCT07003074
Recruiting
Phase 1
A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors
Breast CancerPancreatic CancerOvarian Cancer+1 more
Jiangsu Hansoh Pharmaceutical Co., Ltd.318 enrolled1 locationNCT05740956
Recruiting
Phase 3
A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer
Breast Cancer
InventisBio Co., Ltd640 enrolled2 locationsNCT06954961
Recruiting
Not Applicable
Photoacoustic/Ultrasound Imaging for Breast Nodule Diagnosis, Molecular Classification, and Neoadjuvant Chemotherapy Response Evaluation
Breast CancerBreast MassesBreast Cancer Treated with Neoadjuvant Chemotherapy
Peking Union Medical College Hospital500 enrolled1 locationNCT06908291
Recruiting
Phase 1
A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast Cancer
Breast Cancer
Shandong Suncadia Medicine Co., Ltd.102 enrolled1 locationNCT05628870
Recruiting
Phase 2
Efficacy and Safety Study of Disitamab Vedotin + RC148 vs. Albumin-Paclitaxone ± Toripalimab in HR-/HER2-low Breast Cancer
Breast Cancer
RemeGen Co., Ltd.40 enrolled1 locationNCT06642545
Recruiting
Phase 1Phase 2
TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer
Breast CancerBreast Cancer MetastaticBreast Carcinoma+1 more
Essen Biotech85 enrolled1 locationNCT06532812